Based in Charlotte, North Carolina, cbdMD, Inc. manufactures and distributes cannabidiol (CBD) and hemp-derived products across multiple consumer categories. The company's primary brand, cbdMD, offers a range of CBD formulations including oils, gummies, capsules, soft-gels, and topicals, alongside hemp-derived Delta-9 THC products compliant with federal regulations. The company operates additional brands serving distinct market segments: Paw CBD focuses on pet wellness products for dogs and cats, including tinctures, chews, and topicals; ATRx markets non-cannabinoid functional ingredients such as functional mushrooms; and Herbal Oasis provides hemp-derived solutions.
The company distributes its products through multiple channels, including direct-to-consumer sales, e-commerce platforms, online marketplaces, and wholesale distribution to retailers and health and pet specialty channels. With 42 full-time employees, cbdMD operates with a relatively lean organizational structure. The company is incorporated in North Carolina and listed on the NYSE.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.09 | $-1.09 | +39.1% | |
| 2024 | $-1.79 | $-1.79 | +86.6% | |
| 2023 | $-13.32 | $-13.32 | -974.2% | |
| 2022 | $-1.24 | $-1.24 | -163.8% | |
| 2021 | $-0.47 | $-0.47 | -267.9% | |
| 2020 | $0.28 | $0.28 | — | |
| 2019 | $0.00 | $-2.82 | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-09-30 | 2025-12-19 | 0001437749-25-038435 | SEC ↗ |
| 2024-09-30 | 2024-12-18 | 0001437749-24-037840 | SEC ↗ |
| 2023-09-30 | 2023-12-22 | 0001437749-23-035228 | SEC ↗ |
| 2022-09-30 | 2022-12-15 | 0001437749-22-029136 | SEC ↗ |
| 2021-09-30 | 2021-12-17 | 0001654954-21-013292 | SEC ↗ |
| 2020-09-30 | 2020-12-22 | 0001654954-20-013835 | SEC ↗ |
| 2019-09-30 | 2019-12-18 | 0001654954-19-014052 | SEC ↗ |
| 2018-09-30 | 2018-12-12 | 0001654954-18-013865 | SEC ↗ |
| 2017-09-30 | 2017-12-26 | 0001654954-17-011858 | SEC ↗ |